Good Steward Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Sell
4,219
-77
-2% -$4.49K 0.16% 56
2025
Q4
$232K Sell
4,296
-2,088
-33% -$100K 0.15% 65
2025
Q3
$288K Sell
6,384
-3,691
-37% -$172K 0.2% 61
2025
Q2
$466K Sell
10,075
-8,855
-47% -$435K 0.37% 43
2025
Q1
$1.15M Buy
+18,930
New +$1.1M 1.05% 21

Other funds holding BMY

Good Steward Wealth Advisors's BMY Position: Q1 2026 in Review

Good Steward Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, selling an estimated $4.49K and leaving 4,219 shares worth $256K. The position accounts for 0.16% of the portfolio, ranked #56.

Good Steward Wealth Advisors first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.15M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Good Steward Wealth Advisors held 4,219 shares of Bristol-Myers Squibb worth $256K as of Q1 2026.
  • Good Steward Wealth Advisors sold 77 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.49K.
  • Bristol-Myers Squibb made up 0.16% of Good Steward Wealth Advisors's portfolio in Q1 2026, its #56 holding.
  • Good Steward Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • Good Steward Wealth Advisors's Bristol-Myers Squibb position peaked at $1.15M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Good Steward Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.